Zurich Cantonal Bank’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $407K | Buy |
44,108
+25,316
| +135% | +$233K | ﹤0.01% | 1780 |
|
|
2025
Q1 | $161K | Buy |
18,792
+16,453
| +703% | +$141K | ﹤0.01% | 2204 |
|
|
2024
Q4 | $25.1K | Sell |
2,339
-491
| -17% | -$5.27K | ﹤0.01% | 2587 |
|
|
2024
Q3 | $16.1K | Sell |
2,830
-52
| -2% | -$295 | ﹤0.01% | 2605 |
|
|
2024
Q2 | $12.2K | Sell |
2,882
-25,663
| -90% | -$108K | ﹤0.01% | 2611 |
|
|
2024
Q1 | $145K | Buy |
28,545
+7,874
| +38% | +$40.1K | ﹤0.01% | 2219 |
|
|
2023
Q4 | $192K | Buy |
20,671
+7,298
| +55% | +$67.9K | ﹤0.01% | 2097 |
|
|
2023
Q3 | $87.6K | Hold |
13,373
| – | – | ﹤0.01% | 2414 |
|
|
2023
Q2 | $109K | Hold |
13,373
| – | – | ﹤0.01% | 2314 |
|
|
2023
Q1 | $115K | Hold |
13,373
| – | – | ﹤0.01% | 2212 |
|
|
2022
Q4 | $124K | Buy |
13,373
+3,470
| +35% | +$32.1K | ﹤0.01% | 2141 |
|
|
2022
Q3 | $102K | Hold |
9,903
| – | – | ﹤0.01% | 2204 |
|
|
2022
Q2 | $99K | Hold |
9,903
| – | – | ﹤0.01% | 2251 |
|
|
2022
Q1 | $122K | Hold |
9,903
| – | – | ﹤0.01% | 2188 |
|
|
2021
Q4 | $172K | Hold |
9,903
| – | – | ﹤0.01% | 2169 |
|
|
2021
Q3 | $178K | Hold |
9,903
| – | – | ﹤0.01% | 1999 |
|
|
2021
Q2 | $226K | Buy |
+9,903
| New | +$226K | ﹤0.01% | 1727 |
|